Laila Gharzai MD LLM

Throat cancer survivor Paula Ruska and her doctor, @LGharzai , mark National #cancersurvivormonth by sharing their experience and discussing the need for continued care after treatment. news.northwestern.edu/stories/2025/0…

Unmet needs such as transport and finances forcing cancer patients to miss imaging appointments. @UCIMedSchool @RadiologyACR @JACRJournal @LGharzai ow.ly/cBkV50VyVRT

Our team demonstrates the first ever validation of COST Item 12 as a single item screening measure for financial toxicity—can be used as a brief, single item screener with excellent sensitivity for detecting patients at high risk of financial distress. ascopubs.org/doi/10.1200/OP…

Asking patients for guidance based on their lived experience is key, says Lurie Cancer Center's Laila Gharzai, MD, (@LGharzai), co-author of a recent study about #financialtoxicity screening preferences in @JCOOP_ASCO. "They've actually been through it."

Short summary PRO measures offer the opportunity to frequently screen patients undergoing treatment without unduly burdening patients. We show that FACT GP5, assessing side effect bother, is a promising summary measure for head/neck cancer patients. link.springer.com/article/10.100…

@OncLive Face-Off between @UChicagoHemOnc and @NorthwesternMed ! Debated lung cancer, while discussing our rivalry! Purple vs Maroon! @your_hemoncdoc @JPatelMD @LGharzai @DivyaGuptaMD With judges @DrRoyHerbstYale @DrEdKim @JSabari

Poster #282 right now in the exhibit hall!

Check out our paper on screening for financial toxicity in patients with cancer! #LeilaMady @LGharzai @hopkins_ent Preventing and addressing FT begins with detecting it. We discuss the available tools, best practices, and common risk factors. jacr.org/article/S1546-…

Surrogate endpoints for HPV+ HN cancer; an analysis of 5 NRG Oncology studies. LRPFS, DMFS, and PFS seem to fit the bill. authors.elsevier.com/c/1ifvZ5EIIgPd… @LGharzai

Excited to share our work showing the first validation of surrogate endpoints in HPV+ oropharyngeal cancer! We show that LRPFS, DMFS, and PFS correlate with 5yr OS. Important for trial design in this evolving dx space @MierzwaMichelle @StatMatt9 @NRGonc sciencedirect.com/science/articl…

The FACT-HN-RAD offers a means to serially monitor patients with radiation therapy-related adverse effects and recovery over time in both the clinical and research settings. ja.ma/3sfS84e @lgharzai @mierzwamichelle

LCRF Together Chicago is June 6 at The Ivy Room! Join our gathering & educational event with Drs. Nisha Mohindra, Jessica Donington, Laila A. Gharzai, & Melanie M. Smith; and moderator Ivy Elkins. Refreshments 5:30 PM; panel 6:30 PM. RSVP: LCRF.org/togetherchicago. #LungCancer

Original Article: “Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer,” by @LGharzai et al. eviden.cc/3zeUxg1 #OncoAlert #MedTwitter

Read our April 15 issue! 📗 acsjournals.onlinelibrary.wiley.com/toc/10970142/2… ✔️ Top advances in hepatobiliary cancer by @TimGreten & Coffman-D’Annibale ✔️ @BevGreen6 on DIP & nonadherence to health-protective behaviors ✔️ @lgharzai @reshmajagsi on financial toxicity & clinical trial design

We are ✨ECSTATIC✨ to have you all join us TOMORROW for Northwestern's 5th annual Women in Medicine conference! While online registration is closed, onsite registration will be available during the conference! 🎉Looking forward to seeing you all🎉

Financial impact of therapies should be measured. Patients who are informed of therapy implications—efficacy, side effects, cost, & financial impact—are able to select the best cancer treatment for themselves. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @lgharzai @reshmajagsi CC: @VivekSubbiah

Don’t miss the @LurieCancer Multidisciplinary Head & Neck Symposium Dec. 2-3 @NorthwesternMed. The agenda features internationally-recognized experts in the diagnosis, treatment and rehabilitation of #HeadandNeckCancer patients: cancer.northwestern.edu/events/profess… #LurieHNC #HNCSM #CME

Had a fantastic time today chatting with my @CBSSM folks today on financial toxicity research I’ve done with @reshmajagsi, ways we can mitigate this devastating phenomenon…and experiencing my first zoom bomb!